litlas
Log inCreate account

Peter K. Kaiser

Active 1982–2025

129
Papers
30,742
Citations
77
h-index
125
i10-index

Citations

Citations per year for Peter K. Kaiser1952: 1 citations1965: 3 citations1972: 1 citations1986: 2 citations1987: 2 citations1988: 2 citations1989: 3 citations1990: 11 citations1991: 26 citations1992: 41 citations1993: 38 citations1994: 35 citations1995: 31 citations1996: 24 citations1997: 12 citations1998: 29 citations1999: 29 citations2000: 23 citations2001: 18 citations2002: 29 citations2003: 17 citations2004: 28 citations2005: 52 citations2006: 66 citations2007: 147 citations2008: 186 citations2009: 167 citations2010: 214 citations2011: 194 citations2012: 218 citations2013: 235 citations2014: 245 citations2015: 250 citations2016: 191 citations2017: 192 citations2018: 159 citations2019: 633 citations2020: 645 citations2021: 683 citations2022: 451 citations2023: 396 citations2024: 754 citations2025: 330 citations2026: 6 citations1953–1964: no citations, so these years are not shown1966–1971: no citations, so these years are not shown1973–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,855 citing papers, 27.5% of this breakdownUnited Kingdom: 535 citing papers, 7.9% of this breakdownGermany: 407 citing papers, 6% of this breakdownChina: 384 citing papers, 5.7% of this breakdownItaly: 297 citing papers, 4.4% of this breakdownJapan: 296 citing papers, 4.4% of this breakdownAustralia: 282 citing papers, 4.2% of this breakdownSwitzerland: 271 citing papers, 4% of this breakdownCanada: 222 citing papers, 3.3% of this breakdownFrance: 220 citing papers, 3.3% of this breakdownIndia: 165 citing papers, 2.4% of this breakdownSouth Korea: 139 citing papers, 2.1% of this breakdown
0%27.5%Other 24.8%

Institutions

Fields

  • Medicine75.6%
  • Biochemistry, Genetics and Molecular Biology10.4%
  • Immunology and Microbiology4.4%
  • Engineering3.7%
  • Neuroscience3.3%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other2%

Topics

  • Retinal Diseases and Treatments21.2%
  • Retinal Imaging and Analysis8.6%
  • Ocular Diseases and Behçet’s Syndrome6.8%
  • Ophthalmology and Visual Impairment Studies5.9%
  • Retinal and Macular Surgery4.8%
  • Retinal and Optic Conditions3.9%
  • Other48.8%

Coauthors

All papers

Open in search
  1. Ranibizumab for Neovascular Age-Related Macular Degeneration

    Authors: Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier, David S. Boyer, Peter K. Kaiser, Carol Chung, Robert Y. Kim - New England Journal of Medicine 2006 cited by 5,866

  2. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

    Authors: Jeffrey S. Heier, David M. Brown, Victor Chong, Jean‐François Korobelnik, Peter K. Kaiser, Quan Dong Nguyen, Bernd Kirchhof, Allen C. Ho, Yuichiro Ogura, George D. Yancopoulos, Neil Stahl, Robert Vitti, Alyson J. Berliner, Yuhwen Soo, Majid Anderesi, Georg Groetzbach, Bernd Sommerauer, Rupert Sandbrink, Christian Simader, Ursula Schmidt‐Erfurth - Ophthalmology 2012 cited by 2,470

  3. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

    Authors: Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi, Ramin Tadayoni, Carl J. Danzig, David Eichenbaum, Jason Hsu, Charles C. Wykoff, Jeffrey S. Heier, David R. Lally, Jordi Monés, Jared S. Nielsen, Veeral Sheth, Peter K. Kaiser, Julie Clark, Liansheng Zhu, Hersh Patel, Justin Tang, Dhaval Desai, Glenn J. Jaffe, Arturo Alezzandrini, A Francone, Joaquín Bafalluy, Silvina Bainttein, Silvina Bainttein, Mario Saravia, Matko Vidosevich, Carlos Zeolite, Federico Furno Sola, Andrew Chang, Elisa E. Cornish, Thanh N. Nguyen, Oliver Findl, Anton Haas, Martina Kralinger, Stefan Sacu, Laurence Postelmans, Michel Eid Farah, Maurício Maia, Márcio Bittar Nehemy, Fareed Ali, Michael H. Brent, Michael Dollin, John R. Gonder, Amin Kherani, Andrew Merkur, Raman Tuli, Monica Marie Lopera, Francisco J. Rodríguez, Mario Bradvica, Jan Ernest, Kuldar Kalijurand, Kai Noor, Yves Cohen, Catherine Creuzot‐Garcher, F. De Bats, François Devin, Catherine Français-Maury, Laurent Kodjikian, Jean François Korobelnik, Y. Le Mer, M. Quaranta El Maftouhi, Sam Razavi, Eric H. Souied, Ramin Tadayoni, Michel Weber, Nicole Eter, Nicolas Feltgen, Salvatore Grisanti, Peter Walter, Raffael Liegl, Katrin Lorenz, Georg Spital, Siegfried Priglinger, Martin S. Spitzer, Michael Völker, Tim U. Krohne, Claudia Jochmann, Chris P. Lohmann, Carsten Framme, Ágnes Kerényi, András Papp, András Seres, Edit Tóth‐Molnár, Alexis Tsorbatzoglou, A VAJAS, Balázs Varsányi, Gábor Vogt, Asaf Bar, Eva Eting, David Hauser, Jamie Levy, Nurit Mathalone, Haia Morori-Katz, Irit Rosenblatt, Shiri Soudry-Zayit, Omert Trivizky, Francesco Bandello, Antonio P. Ciardella, Michele Figus and 126 more - The Lancet 2023 cited by 315

  4. Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

    Authors: David M. Brown, Peter K. Kaiser, Mark Michels, G. Soubrane, Jeffrey S. Heier, Robert Y. Kim, Judy P. Sy, Susan Schneider - New England Journal of Medicine 2006 cited by 3,503

  5. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab

    Authors: Jordi Monés, Sunil Srivastava, Glenn J. Jaffe, Ramin Tadayoni, Thomas A. Albini, Peter K. Kaiser, Frank G. Holz, Jean‐François Korobelnik, Ivana K. Kim, Christian Pruente, Timothy G. Murray, Jeffrey S. Heier - Ophthalmology 2020 cited by 349

  6. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

    Authors: David M. Brown, Mark Michels, Peter K. Kaiser, Jeffrey S. Heier, Judy P. Sy, Tsontcho Ianchulev - Ophthalmology 2008 cited by 1,316

  7. Review of gene therapies for age-related macular degeneration

    Authors: Arshad M. Khanani, Mathew Thomas, Aamir Aziz, Christina Y. Weng, Carl J. Danzig, Glenn Yiu, Szilárd Kiss, Nadia K. Waheed, Peter K. Kaiser - Eye 2022 cited by 115

  8. Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

    Authors: Ursula Schmidt‐Erfurth, Peter K. Kaiser, Jean‐François Korobelnik, David M. Brown, Victor Chong, Quan Dong Nguyen, Allen C. Ho, Yuichiro Ogura, Christian Simader, Glenn J. Jaffe, Jason S. Slakter, George D. Yancopoulos, Neil Stahl, Robert Vitti, Alyson J. Berliner, Yuhwen Soo, Majid Anderesi, Olaf Sowade, Oliver Zeitz, Christiane Norenberg, Rupert Sandbrink, Jeffrey S. Heier - Ophthalmology 2013 cited by 811

  9. The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole

    Authors: Jay S. Duker, Peter K. Kaiser, Susanne Binder, Marc D. de Smet, Alain Gaudric, Elias Reichel, Srinivas Sadda, J. Sebag, Richard F. Spaide, Peter Stalmans - Ophthalmology 2013 cited by 1,173

  10. Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF Therapy

    Authors: Andrei-Alexandru Szigiato, Nitesh Mohan, Katherine E. Talcott, Danny A. Mammo, Amy Babiuch, Peter K. Kaiser, Justis P. Ehlers, Aleksandra Rachitskaya, Alex Yuan, Sunil K. Srivastava, Sumit Sharma - Ophthalmology Retina 2023 cited by 63

  11. Intravitreal Aflibercept for Diabetic Macular Edema

    Authors: Jean‐François Korobelnik, V. Diana, Ursula Schmidt‐Erfurth, David S. Boyer, Frank G. Holz, Jeffrey S. Heier, Edoardo Midena, Peter K. Kaiser, Hiroko Terasaki, Dennis M. Marcus, Quan Dong Nguyen, Glenn J. Jaffe, Jason S. Slakter, Christian Simader, Yuhwen Soo, Thomas Schmelter, George D. Yancopoulos, Neil Stahl, Robert Vitti, Alyson J. Berliner, Oliver Zeitz, Carola Metzig, David M. Brown - Ophthalmology 2014 cited by 807

  12. Intravitreal Aflibercept for Diabetic Macular Edema

    Authors: Jeffrey S. Heier, Jean‐François Korobelnik, David M. Brown, Ursula Schmidt‐Erfurth, V. Diana, Edoardo Midena, David S. Boyer, Hiroko Terasaki, Peter K. Kaiser, Dennis M. Marcus, Quan Dong Nguyen, Glenn J. Jaffe, Jason S. Slakter, Christian Simader, Yuhwen Soo, Thomas Schmelter, Robert Vitti, Alyson J. Berliner, Oliver Zeitz, Carola Metzig, Frank G. Holz - Ophthalmology 2016 cited by 421

  13. Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration

    Authors: Frank G. Holz, Piotr Oleksy, Federico Ricci, Peter K. Kaiser, Joachim Kiefer, Steffen Schmitz-Valckenberg - Ophthalmology 2021 cited by 67

  14. Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care

    Authors: Marc J. Sirks, Elon H. C. van Dijk, Noa Rosenberg, Carla E. M. Hollak, Stamatios Aslanis, Chui Ming Gemmy Cheung, Itay Chowers, Chiara M. Eandi, K. Bailey Freund, Frank G. Holz, Peter K. Kaiser, Andrew Lotery, Kyoko Ohno‐Matsui, Giuseppe Querques, Yousif Subhi, Ramin Tadayoni, Charles C. Wykoff, Dinah Zur, Roselie M.H. Diederen, Camiel J.F. Boon, Reinier O. Schlingemann - Acta Ophthalmologica 2022 cited by 88

  15. RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

    Authors: Peter K. Kaiser, Charles C. Wykoff, Rishi P. Singh, Arshad M. Khanani, V. Diana, Hersh Patel, Nikhil Patel - Retina 2021 cited by 72

  16. Pipeline therapies for neovascular age related macular degeneration

    Authors: Sruthi Arepalli, Peter K. Kaiser - International Journal of Retina and Vitreous 2021 cited by 42

  17. Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration

    Authors: Arshad M. Khanani, Marco A. Zarbin, Mark Barakat, Thomas A. Albini, Peter K. Kaiser, B Guruprasad, Neetu Agashivala, Justin S. Yu, Charles C. Wykoff, Mathew W. MacCumber - JAMA Ophthalmology 2021 cited by 114

  18. The 5 min meta-analysis: understanding how to read and interpret a forest plot

    Authors: Yaping Chang, Mark Phillips, Robyn H. Guymer, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, on behalf of the R.E.T.I.N.A. study group, Charles C. Wykoff, Sobha Sivaprasad, Peter K. Kaiser, David Sarraf, Sophie J. Bakri, Sunir J. Garg, Rishi P. Singh, Frank G. Holz, Tien Yin Wong - Eye 2022 cited by 65

  19. Longitudinal Assessment of Ellipsoid Zone Integrity, Subretinal Hyperreflective Material, and Subretinal Pigment Epithelium Disease in Neovascular Age-Related Macular Degeneration

    Authors: Justis P. Ehlers, Robert Zahid, Peter K. Kaiser, Jeffrey S. Heier, David M. Brown, Xiangyi Meng, Jamie Reese, Thuy Le, Leina Lunasco, Ming Hu, Sunil K. Srivastava - Ophthalmology Retina 2021 cited by 65

  20. RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by Sirna-027

    Authors: Peter K. Kaiser, R. C. Andrew Symons, Syed Mahmood Shah, Edward Quinlan, Homayoun Tabandeh, V. Diana, Gail Reisen, Jennifer A. Lockridge, Brian Short, Roberto Guerciolini, Quan Dong Nguyen - American Journal of Ophthalmology 2010 cited by 193

  21. Tryptophan metabolism is a physiological integrator regulating circadian rhythms

    Authors: Paul Petrus, Marlene Cervantes, Muntaha Samad, Tomoki Sato, Alina Chao, Shogo Sato, Kevin B. Koronowski, Grace Park, Yasmine Alam, Niklas Mejhert, Marcus Seldin, José Manuel Monroy Kuhn, Kenneth A. Dyar, Dominik Lutter, Pierre Baldi, Peter K. Kaiser, Cholsoon Jang, Paolo Sassone‐Corsi - Molecular Metabolism 2022 cited by 51

  22. The DISCOVER Study 3-Year Results

    Authors: Justis P. Ehlers, Yasha S. Modi, Paula E. Pecen, Jeffrey M. Goshe, William J. Dupps, Aleksandra Rachitskaya, Sumit Sharma, Alex Yuan, Rishi P. Singh, Peter K. Kaiser, Jamie Reese, Carmen Calabrise, Allison Watts, Sunil K. Srivastava - Ophthalmology 2018 cited by 137

  23. Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index

    Authors: Justis P. Ehlers, Atsuro Uchida, Ming Hu, Natália Figueiredo, Peter K. Kaiser, Jeffrey S. Heier, David M. Brown, David S. Boyer, V. Diana, Andrea Gibson, Namrata Saroj, Sunil K. Srivastava - Ophthalmology Retina 2019 cited by 72

  24. ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR BIOSIMILARS IN OPHTHALMOLOGY

    Authors: Peter K. Kaiser, Marc Steffen Schmitz-Valckenberg, Frank G. Holz - Retina 2022 cited by 52